Overview

NAC for Hematopoietic Recovery in SAA

Status:
NOT_YET_RECRUITING

Trial end date:
2025-07-01

Target enrollment:

Participant gender:

Summary

This is a prospective single-arm clinical study to evaluate the role of NAC among patients with severe aplastic anemia (SAA) can promote hematopoietic recovery after haploidentical transplantation.

Phase:

PHASE2

Details

Lead Sponsor:

Peking University People's Hospital

Treatments:

Acetylcysteine